“Chronic Kidney Disease in Type 2 Diabetes: A Narrative Review of SGLT2 Inhibitor Uptake and the Gap Between Guideline and Prescription” (2025) Journal of Clinical Diabetes and Obesity, 5(1), pp. 31–36. doi:10.5281/zenodo.22261282.